Taken together, SET played a positive role in regulating ovarian androgen biosynthesis by enhancing transcription of CYP17 and HSD3B2, which may participate in hyperandrogenism of PCOS. The gene discussed is CYP17A1; the disease is polycystic ovary syndrome.